CALR-BRD2 Fusion FISH Probe
The CALR-BRD2 Fusion FISH Probe is used to confirm a fusion of the CALR and BRD2 genes. The fusion of the CALR and BRD2 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
CALR-BRD2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-RERE | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-REOR | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-REGO | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-REGR | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-REAQ | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-ORRE | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-OROR | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-ORGO | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-ORAQ | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-GORE | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-GOOR | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-GOGO | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-GOGR | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-GOAQ | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-GRRE | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-GROR | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-GRGO | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-GRGR | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-GRAQ | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-AQRE | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-AQOR | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-AQGO | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-AQGR | 20 (40 μL) | 200 μL | ||
CALR-BRD2-20-AQAQ | 20 (40 μL) | 200 μL |
CALR Gene Summary
Calreticulin is a multifunctional protein that acts as a major Ca(2+)-binding (storage) protein in the lumen of the endoplasmic reticulum. It is also found in the nucleus, suggesting that it may have a role in transcription regulation. Calreticulin binds to the synthetic peptide KLGFFKR, which is almost identical to an amino acid sequence in the DNA-binding domain of the superfamily of nuclear receptors. Calreticulin binds to antibodies in certain sera of systemic lupus and Sjogren patients which contain anti-Ro/SSA antibodies, it is highly conserved among species, and it is located in the endoplasmic and sarcoplasmic reticulum where it may bind calcium. The amino terminus of calreticulin interacts with the DNA-binding domain of the glucocorticoid receptor and prevents the receptor from binding to its specific glucocorticoid response element. Calreticulin can inhibit the binding of androgen receptor to its hormone-responsive DNA element and can inhibit androgen receptor and retinoic acid receptor transcriptional activities in vivo, as well as retinoic acid-induced neuronal differentiation. Thus, calreticulin can act as an important modulator of the regulation of gene transcription by nuclear hormone receptors. Systemic lupus erythematosus is associated with increased autoantibody titers against calreticulin but calreticulin is not a Ro/SS-A antigen. Earlier papers referred to calreticulin as an Ro/SS-A antigen but this was later disproven. Increased autoantibody titer against human calreticulin is found in infants with complete congenital heart block of both the IgG and IgM classes. [provided by RefSeq, Jul 2008]
Gene Name: Calreticulin
Chromosome: CHR19: 13049413 -13055304
Locus: 19p13.13
BRD2 Gene Summary
This gene encodes a transcriptional regulator that belongs to the BET (bromodomains and extra terminal domain) family of proteins. This protein associates with transcription complexes and with acetylated chromatin during mitosis, and it selectively binds to the acetylated lysine-12 residue of histone H4 via its two bromodomains. The gene maps to the major histocompatability complex (MHC) class II region on chromosome 6p21.3, but sequence comparison suggests that the protein is not involved in the immune response. This gene has been implicated in juvenile myoclonic epilepsy, a common form of epilepsy that becomes apparent in adolescence. Multiple alternatively spliced variants have been described for this gene. [provided by RefSeq, Dec 2010]
Gene Name: Bromodomain Containing 2
Chromosome: CHR6_ssto_hap7: 4367204 -4430060
Locus: 6p21.32
Gene Diseases
The CALR BRD2 Fusion has been associated with the following diseases:
Disease Name |
---|
Prostate Adenocarcinoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|